BMSN STOCK no FDA approval this year or it may never happen as FDA will have ebola approval first on list now and this stock is going lower as i am seeing a huge trend line downward coming for stock as koos plans of having one stock and using BMSN to start huge diluting of shares.THIS STOCK next week heading down below .0011 levels as koos will have a huge R/S/M before year end.strong sell
___________ As always,, the above Post is "Just My Opinion!"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
